SEC Form 4 · accession 0001209191-17-063037
HTG MOLECULAR DIAGNOSTICS, INC · HTGM
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Harry A. George
Director
Period of report
Nov 29, 2017
Accepted (ET)
Nov 30, 2017 · 4:52 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001169987
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Nov 29, 2017 | A | 4,030 | $2.14 | A | 34,030 | D | |
| Common StockF2 | holding | — | — | — | 144,366 | I | By Entities affiliated with Solstice Capital |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The shares were acquired by the Reporting Person pursuant to the Issuer's Amended and Restated Stock Purchase Plan adopted December 1, 2015, as amended January 21, 2016.
- F2The Reporting Person is the managing member of Solstice Capital and has joint voting and investment power over the shares held by Solstice Capital.